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In this study, we report the first outbreak of KPC-2-producing Klebsiella pneumoniae isolates from three patients admitted to a
neurosurgery department in a South Korean teaching hospital. Multilocus sequence typing showed that the isolates were identi-
cal to the previous KPC producers in South Korea and other countries, suggesting clonal spread.
KPC enzymes hydrolyze carbapenems and are the most clini-cally significant enzymes among class A carbapenemases (1).
The first KPC-1-producing Klebsiella pneumoniae isolate was de-
tected in 1996 in the United States (2). Thereafter, KPC-2 and its
variant producers have caused severe treatment problems in hos-
pitals around New York and have also been reported in Europe,
South America, and China (1). In South Korea, only two cases of
infection with KPC-2-producing K. pneumoniae had been re-
ported by 2010 (3, 4). Subsequently, six blaKPC-2-positiveK. pneu-
moniae strains were sporadically isolated from several hospitals
during nationwide surveillance in 2011 (5). To date, no outbreaks
of KPC-2-producing K. pneumoniae have been reported in a uni-
versity-affiliated hospital in South Korea.
(Some of the data in this work were presented at the 22nd
European Congress of Clinical Microbiology and Infectious Dis-
eases, London, United Kingdom, 31 March to 3 April 2012.)
In the present study, we isolated non-carbapenem-susceptible
K. pneumoniae isolates from three patients admitted to the neu-
rosurgery (NS) department in an 870-bed teaching hospital in
South Korea over a 5-week period. All three patients were admit-
ted for the treatment of central nervous system (CNS) lesions.
One patient underwent craniotomy for the resection of a CNS
tumor, and two patients received catheter insertions for intracra-
nial hemorrhage. For postoperative care, these patients were ad-
mitted to the neurosurgical intensive care unit (ICU) from 2 to 49
days. The patients received mechanical ventilation. The periods
spent by two patients in the ICU overlapped. After acute manage-
ment, all three patients were transferred to the same NS general
ward. On 12 July 2011, the first non-carbapenem-susceptible K.
pneumoniae strain was isolated from one of the three patients
admitted to theNS general ward, and two consecutive strains were
isolated over a 5-week period. Two KPC-producing isolates were
found to be the cause of pneumonia, and one isolate caused
asymptomatic bacteriuria. The first patient received 4.5 g pipera-
cillin-tazobactam three times a day for 50 days followed by 1.0 g
cefepime twice daily for 28 days before the outbreak-causing
strain was isolated. The second patient received 1.0 g imipenem-
cilastatin twice daily for 19 days. The pneumonia cases caused by
KPC-producing isolates were cured. The third patient was treated
with 1.0 g meropenem twice daily for 20 days before the isolation
of the KPC-producing strain (Table 1).
Bacterial identification and susceptibility tests were routinely
performed using the Vitek 2 system (bioMérieux, Marcy l’Étoile,
France). The antimicrobial susceptibilities were interpreted ac-
cording to the Clinical and Laboratory Standards Institute 2011
guidelines (6). In previous SouthKorean studies, the first isolate of
KPC-2-producing K. pneumoniae exhibited multidrug resistance
to various antibiotics, including colistin (3), while the second iso-
late was susceptible to gentamicin, tigecycline, and colistin (4). Six
surveillance isolates of KPC-2-producing K. pneumoniae exhib-
ited high MICs of carbapenems (32 mg/liter) and multidrug
resistance, with the exception of susceptibility to tigecycline and
colistin (5). Unlike previous studies, in our study, two isolates of
KPC-producing K. pneumoniae exhibited intermediate suscepti-
bility to imipenem (MIC, 2 mg/liter) and meropenem (MIC, 2
mg/liter); however, one isolate was resistant to imipenem (MIC, 4
mg/liter) and meropenem (MIC, 16 mg/liter) (Table 2). Car-
bapenemase production was confirmed by the modified Hodge
test (7). In order to classify the types of carbapenem resistance
mechanisms, we used a combination test of carbapenem and
-lactamase inhibitor disks (Neo-Sensitabs and Diatabs; Rosco
Diagnostica, Denmark). Boronic acid exhibited inhibitory effects
(5-mm enlargement) on all three non-carbapenem-susceptible
strains, but the inhibitory zones of cloxacillin- and dipicolinic
acid-containing disks were not enlarged for these strains. The
blaKPC gene was detected by a multiplex PCR that detects the five
class A carbapenemase families (KPC, SME, IMI, NMC-A, and
GES enzymes) (8). The sequence data for the blaKPC-2 genes were
confirmed by using flanking primers (forward primer: 5=-GCT
ACA CCT AGC TCC ACC TTC-3=; reverse primer: 5=-GAC AGT
GGT TGG TAA TCC ATG C-3=). PCR amplification of other
-lactamase genes (i.e., blaTEM, blaSHV, blaPSE, blaCTX-M, and
blaAmpC) was performed using family-specific primers. All KPC-
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producing isolates carried three -lactamase genes: blaTEM-like,
blaSHV-like, and blaKPC-2. However, the blaPSE, blaCTX-M, and
blaAmpC genes were not detected in the outbreak strains. The
first KPC-2-producing isolate in South Korea contained a
blaCTX-M-15 gene, but the second isolate and six strains isolated
from a South Korean surveillance study did not harbor this
gene (3–5) (Table 3).
The genetic environments of the blaKPC-2 gene of the three
outbreak strains and a KPN 1010 strain (4) were characterized
by using specific primer pairs (9) and sequenced by PCR map-
ping, based on the sequence of Tn4401. The examined environ-
ments corresponded to that of the variant of Tn4401, isoform a
(10). Plasmid analysis with S1 nuclease digestion (11) showed a
ca. 180-kb band in a representative outbreak strain (data not
shown). Hybridization was carried out with a digoxigenin
(DIG) DNA labeling and detection kit (Roche Diagnostics
GmbH, Mannheim, Germany) as described in a previous re-
port (12), and the blotted band was hybridized with probes
specific for the blaKPC-2 gene.
The pulsed-field gel electrophoresis patterns, obtained with
XbaI digestion, of the outbreak strains were identical. Multilo-
cus sequence typing (MLST) with seven housekeeping genes
(gapA, infB, mdh, pgi, phoE, rpoB, and tonB) was performed
on three KPC-producing K. pneumoniae isolates (13) and
one contemporary extended-spectrum--lactamase-produc-
ing carbapenem-susceptible K. pneumoniae isolate as a control
strain. MLST of the three blaKPC-2-producing isolates resulted
in one sequence type (ST), 258 (allelic profile 3-3-1-1-1-1-79),
but the type of the control strain was ST11 (allelic profile 3-3-
1-1-1-1-4). Although the MLST types of the first South Korean
case of KPC-2-producingK. pneumoniae and our control strain
were ST11, the remaining isolates were ST258 (3–5). The
blaKPC-2 gene-carrying K. pneumoniae ST258 clone has been
identified worldwide, suggesting that it may have contributed
significantly to the spread of blaKPC-2 genes (1). Therefore, we
suspect that KPC-producing K. pneumoniae ST258 may have
spread to South Korea from other countries.
In summary, there has been no outbreak of KPC-2-produc-
ing K. pneumoniae in South Korea thus far. However, in our
hospital, three KPC-2-producing strains were isolated during a
5-week period, and the pulsotypes and sequence types of the
strains were identical. To the best of our knowledge, this is the
first outbreak of KPC-2-producing K. pneumoniae ST258 in
South Korea. Collectively, these results suggest that KPC-2-
producing clones have been spreading in South Korean hospi-
tals and their prevalence may be increasing. Therefore, more
intensive efforts to control the nosocomial spread of KPC-pro-
ducing isolates are warranted.
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